Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1984; 52(01): 094
DOI: 10.1055/s-0038-1661145
DOI: 10.1055/s-0038-1661145
Letter to the Editor
The Release of Platelet Factor 4 (PF4) Induced by Heparin and Related Glycosaminoglycans (GAGs)
Further Information
Publication History
Received 24 April 1984
Accepted 28 May 1984
Publication Date:
21 August 2018 (online)
-
References
- 1 Cofrancesco E, Colombi M, Cristoforetti G, Pogliani EM. Selective PF4 release in vitro induced by heparin and related glycosaminoglycans (GAGs)-Correlation with β-TG release and platelet aggregation. Thromb Haemostas 1984; 51: 105-107
- 2 Fabris F, Celia G, Randi ML, Casonato A, Fussi F, Girolami A. The effect of heparins on platelet release reaction. In Heparin. New biochemical and medical aspects. Witt I. (ed) pp 206-225 DeGruyter, Berlin; New York: 1983
- 3 Dawes J. Physiological heparin. Its function and fate (discussion). In Heparin new biochemical and medical aspects. Witt I. (ed) pp 45-67 DeGruyter Berlin; New York: 1983
- 4 Handin R, Cohen HJ. Purification and binding properties of human platelet factor four. J Biol Chem 1976; 251: 4273-4282
- 5 Busch C, Dawes J, Pepper DS, Wasteson A. Binding of platelet factor 4 to cultured human umbilical vein endothelial cells. Thromb Res 1980; 19: 129-137
- 6 Dawes J, Punphrey CW, McLaren KM, Prowse CV, Pepper DS. The in vivo release of human platelet factor 4 by heparin. Thromb Res 1982; 27: 65-76
- 7 Randi ML, Fabris F, Casonato A, Scattolo N, Celia G, Girolami A. The effect of increasing heparin doses and of heparinoid on platelet factor 4 release (PF4) in normal plasma. Haematol. 1983 (in press)
- 8 Ludlam CA, Allan N, Blandford RB, Dowdle R, Bentley NJ, Bloom AL. Platelet and coagulation function in patients with abnormal cardiac valves treated with sulfinpyrazone. Thromb Haemostas 1981; 46: 743-746
- 9 Cella G, Colby SI, Taylor AD, McCracken L, Parisi AF, Sasahara AA. Platelet factor 4 (PF4) and heparin released platelet factor 4 HR-PF4) in patients with cardiovascular disorders. Thromb Res 1983; 29: 499-509